Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,889
archived clinical trials in
Blood Cancer

Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Phase I/II Investigation of Temsirolimus Plus Lenalidomide in Relapsed Non-Hodgkin Lymphomas
Status: Enrolling
Updated:  12/31/1969
274
mi
from 43215
Chicago, IL
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Phase I/II Investigation of Temsirolimus Plus Lenalidomide in Relapsed Non-Hodgkin Lymphomas
Status: Enrolling
Updated: 12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Phase I/II Investigation of Temsirolimus Plus Lenalidomide in Relapsed Non-Hodgkin Lymphomas
Status: Enrolling
Updated:  12/31/1969
351
mi
from 43215
Springfield, IL
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Phase I/II Investigation of Temsirolimus Plus Lenalidomide in Relapsed Non-Hodgkin Lymphomas
Status: Enrolling
Updated: 12/31/1969
Southern Illinois University School of Medicine
351
mi
from 43215
Springfield, IL
Click here to add this to my saved trials
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Phase I/II Investigation of Temsirolimus Plus Lenalidomide in Relapsed Non-Hodgkin Lymphomas
Status: Enrolling
Updated:  12/31/1969
406
mi
from 43215
Saint Louis, MO
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Phase I/II Investigation of Temsirolimus Plus Lenalidomide in Relapsed Non-Hodgkin Lymphomas
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital Saint Louis
406
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
768
mi
from 43215
Lecanto, FL
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Cancer & Blood Disease Center
768
mi
from 43215
Lecanto, FL
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
164
mi
from 43215
Ann Arbor, MI
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
362
mi
from 43215
Chattanooga, TN
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Associates in Oncology and Hematology
362
mi
from 43215
Chattanooga, TN
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
2007
mi
from 43215
Seattle, WA
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
1644
mi
from 43215
Scottsdale, AZ
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic
1644
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
1974
mi
from 43215
Burbank, CA
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Providence St. Joseph Medical Center
1974
mi
from 43215
Burbank, CA
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
2083
mi
from 43215
Santa Rosa, CA
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
St. Jude Hospital Yorba Linda DBA, St. Joseph Heritage Healthcare
2083
mi
from 43215
Santa Rosa, CA
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
2100
mi
from 43215
Stanford, CA
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Stanford University
2100
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
1161
mi
from 43215
Denver, CO
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Colorado Blood Cancer Institute
1161
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
277
mi
from 43215
Chicago, IL
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
167
mi
from 43215
Indianapolis, IN
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Indiana University Health Melvin And Bren Simon Cancer Center
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
620
mi
from 43215
Kansas City, KA
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
University of Kansas Cancer Center
620
mi
from 43215
Kansas City, KA
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
559
mi
from 43215
Rochester, MN
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
476
mi
from 43215
Hackensack, NJ
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
John Theurer Cancer Center at the Hackensack University Medical Center
476
mi
from 43215
Hackensack, NJ
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
479
mi
from 43215
New York, NY
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
NYU Clinical Cancer Center
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
480
mi
from 43215
New York, NY
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
1081
mi
from 43215
Amarillo, TX
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
The Don & Sybil Harrington Cancer Center
1081
mi
from 43215
Amarillo, TX
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
909
mi
from 43215
Dallas, TX
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Baylor Sammons Cancer Center
909
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
910
mi
from 43215
Dallas, TX
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center at Dallas
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
995
mi
from 43215
Houston, TX
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
1018
mi
from 43215
Temple, TX
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Scott & White Memorial Hospital
1018
mi
from 43215
Temple, TX
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
335
mi
from 43215
Milwaukee, WI
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Froedtert and the Medical College of Wisconsin
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated:  12/31/1969
mi
from 43215
Wien,
Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Medizinische Universitat Wien
mi
from 43215
Wien,
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
1946
mi
from 43215
Pomona, CA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
New Hope Cancer & Research Institute
1946
mi
from 43215
Pomona, CA
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
939
mi
from 43215
Atlantis, FL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Medical Specialists of the Palm Beaches
939
mi
from 43215
Atlantis, FL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
943
mi
from 43215
Boynton Beach, FL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
University Cancer Institute, LLC
943
mi
from 43215
Boynton Beach, FL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
809
mi
from 43215
New Port Richey, FL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Pasco Hernando Oncology Associates (Kumar)
809
mi
from 43215
New Port Richey, FL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
582
mi
from 43215
Albany, GA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Phoebe Putney Memorial Hospital
582
mi
from 43215
Albany, GA
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
425
mi
from 43215
Atlanta, GA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Georgia Cancer Specialists
425
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
436
mi
from 43215
Atlanta, GA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Peachtree Hematology-Oncology Consultants
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
513
mi
from 43215
Dublin, GA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
US Oncology - Dublin Hematology & Oncology
513
mi
from 43215
Dublin, GA
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
4501
mi
from 43215
Honolulu, HI
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Straub Clinic And Hospital
4501
mi
from 43215
Honolulu, HI
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
299
mi
from 43215
Arlington Heights, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Arlington
299
mi
from 43215
Arlington Heights, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
277
mi
from 43215
Chicago, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
John H. Stroger, Jr. Hospital of Cook County
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
277
mi
from 43215
Chicago, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
267
mi
from 43215
Harvey, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Ingalls Cancer Research Center
267
mi
from 43215
Harvey, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
291
mi
from 43215
Lombard, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Elmhurst Memorial Hospital
291
mi
from 43215
Lombard, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
286
mi
from 43215
Niles, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Oncology Specialists, S.C.
286
mi
from 43215
Niles, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
286
mi
from 43215
Niles, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles
286
mi
from 43215
Niles, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
356
mi
from 43215
Peoria, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Illinois Cancer Care
356
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
284
mi
from 43215
Skokie, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Orchard Research
284
mi
from 43215
Skokie, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
274
mi
from 43215
Urbana, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Carle Cancer Center
274
mi
from 43215
Urbana, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
298
mi
from 43215
Winfield, IL
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Winfield
298
mi
from 43215
Winfield, IL
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
185
mi
from 43215
Goshen, IN
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Center for Cancer Care @ Goshen Health Systems
185
mi
from 43215
Goshen, IN
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
166
mi
from 43215
Indianapolis, IN
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Indiana University Cancer Center Clinical Research Office
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
202
mi
from 43215
Mishawaka, IN
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Cancer Care Partners, LLC
202
mi
from 43215
Mishawaka, IN
Click here to add this to my saved trials
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated:  12/31/1969
188
mi
from 43215
New Albany, IN
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Status: Enrolling
Updated: 12/31/1969
Cancer Care Center
188
mi
from 43215
New Albany, IN
Click here to add this to my saved trials